This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Antibody Engineering & Therapeutics US
December 14 - 17, 2025
Marriott Marquis San Diego

John Desjarlais, PhD
Chief Scientific Officer at Xencor, Inc.
Speaker

Profile

John Desjarlais is the Chief Scientific Officer of Xencor, where he and his team have built a variety of antibody engineering and enhancement platforms, leading to multiple clinical-stage and approved antibody programs. Prior to Xencor, John was an Assistant Professor of Chemistry at Penn State University. His education includes a Postdoctoral Fellowship at UC Berkeley, a PhD in Biophysics from Johns Hopkins University, and a BS in Physics from UMass Amherst.

Agenda Sessions

  • Co-Chairs' Remarks - Antibody & Protein Therapeutics in Inflammation, Autoimmunity and Allergy

    2:25pm